Publications by authors named "Ramit Magen Rimon"

Background And Aims: Observational healthcare data are an important tool for delineating patients' inflammatory bowel disease (IBD) journey in real-world settings. However, studies that characterize IBD cohorts typically rely on a single resource, apply diverse eligibility criteria, and extract variable sets of attributes, making comparison between cohorts challenging. We aim to longitudinally describe and compare IBD patient cohorts across multiple geographic regions, employing unified data and analysis framework.

View Article and Find Full Text PDF

Background And Aims: Data on upadacitinib therapy in children with ulcerative colitis (UC) or unclassified inflammatory bowel disease (IBD-U) are scarce. We aimed to evaluate the effectiveness and safety of upadacitinib as an induction therapy in pediatric UC or IBD-U.

Methods: In this multicenter retrospective study, children treated with upadacitinib for induction of remission of active UC or IBD-U from 30 centers worldwide were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • Food plays a critical role in the development of inflammatory bowel diseases (IBD), which are chronic immune-related issues in the digestive system.
  • The introduction of exclusive enteral nutrition (EEN) has transformed treatment for Crohn's disease by helping to induce remission and improving understanding of disease mechanics.
  • This review focuses on summarizing current research about how various diets can impact symptoms and the inflammatory processes associated with IBD.
View Article and Find Full Text PDF

Objective: A constitutional disease-causing variant (DCV) in the SMAD4 or BMPR1A genes is present in 40%-60% of patients with juvenile polyposis syndrome (JPS). The aim of this study was to characterize the clinical course and polyp burden in children with DCV-positive JPS compared to DCV-negative JPS.

Methods: Demographic, clinical, genetic, and endoscopic data of children with JPS were compiled from eight international centers in the ESPHGAN/NASPGHAN polyposis working group.

View Article and Find Full Text PDF
Article Synopsis
  • This nationwide study analyzed the durability of first-line biologics in ulcerative colitis (UC) patients, focusing on monotherapy versus combotherapy with immunomodulators over a median follow-up of 7 years.
  • The results showed that the durability rates for pediatric and adult patients were similar, with 43% of patients maintaining their initial biologic treatment after 5 years.
  • Additionally, anti-TNF biologics demonstrated comparable durability to vedolizumab, but were more effective when used in combination with other therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined the effectiveness of infliximab and adalimumab as first biologic treatments in children with Crohn's disease, using a nationwide cohort from Israel.
  • Results showed that adalimumab monotherapy had significantly better long-term durability compared to infliximab monotherapy, while the two treatments had similar durability when used in combination.
  • Overall, the findings suggest that adalimumab should be considered as the preferred first-line biologic therapy for pediatric Crohn's disease patients.
View Article and Find Full Text PDF

Background And Aims: Thiopurines are an established treatment for pediatric ulcerative colitis (UC). However, data regarding safety and efficacy are lacking. We aimed to determine short and long-term outcome following thiopurines use in children with UC.

View Article and Find Full Text PDF
Article Synopsis
  • A nationwide study analyzed the durability of the first biologic treatment for Crohn's disease (CD) using data from nearly the entire Israeli IBD population from 2005 to 2020.
  • Results showed that adalimumab monotherapy had the highest treatment durability after one and three years compared to vedolizumab and infliximab.
  • The study concluded that combination therapy improves durability for both adalimumab and infliximab, suggesting that anti-TNFs may be the preferred first-line biologics for treating CD.
View Article and Find Full Text PDF

Introduction: The number of people diagnosed with inflammatory bowel disease (IBD) continues to increase in most parts of the world. Although the exact etiology of this chronic intestinal disease is not fully understood, nutritional factors appear to play key roles. Furthermore, individuals with IBD are at increased risk of adverse nutritional impacts, including micronutrient deficiencies.

View Article and Find Full Text PDF

Background: Data regarding patients with ulcerative colitis (UC) not receiving maintenance treatment are scarce. In this nationwide study, we aimed to explore the frequency and long-term outcomes of untreated patients with UC vs treated patients.

Methods: We retrieved data from Israel's Health Maintenance Organizations, covering 98% of the population.

View Article and Find Full Text PDF

Background: 5-aminosalicylates (5-ASA) are widely used in Crohn's disease (CD) despite guidelines advising otherwise. We aimed to assess in nationwide study the outcomes of first-line 5-ASA maintenance therapy (5-ASA-MT) compared with no maintenance treatment (no-MT) in patients with newly diagnosed CD.

Methods: We utilised data from the epi-IIRN cohort, including all patients with CD diagnosed in Israel between 2005 and 2020.

View Article and Find Full Text PDF

Objectives: Escalation of the ustekinumab (UST) maintenance dosage was effective in adults with Crohn disease (CD), but no data are available for children. We evaluated the effectiveness and safety of dose escalation of UST in pediatric CD.

Methods: This was a retrospective multicenter study from 25 centers affiliated with the IBD Interest and Porto groups of ESPGHAN.

View Article and Find Full Text PDF

Aim: Aspartate aminotransferase (AST) is an enzyme expressed in several organs; therefore, AST elevation may reflect outside of liver pathology. AST elevation may also be associated with macro-AST (m-AST). The aim of this study was to evaluate the long-term course of children with prolonged isolated AST elevation and the prevalence of m-AST in our cohort.

View Article and Find Full Text PDF

Bariatric surgery is gaining acceptance as an efficient treatment modality for adults and adolescents with morbid obesity. The early postbariatric period has the potential to induce an immunomodulatory imbalance due to the development or worsening of nutritional deficiencies, changes in hormonal balance (specifically after sleeve gastrectomy), and a shift in the proinflammatory cytokine profile along with a major change in the gut microbiome and permeability. These changes may induce encephalomyelitic T cell activity, change neural barrier permeability, and induce gut dysbioisis, favoring a proinflammatory metabolic profile.

View Article and Find Full Text PDF

Aim: Eosinophilic oesophagitis (EoE) is a chronic inflammatory oesophageal disease, which has become more recognised in the past decade. We wanted to characterise our patients and review their course of disease and response to treatment.

Methods: We retrospectively reviewed the medical records of EoE patients from January 2010 to May 2018 in our Gastroenterology Institute.

View Article and Find Full Text PDF

Aim: Hypertransaminasaemia is a common incidental finding in children. It has been demonstrated that even prolonged elevation usually resolves spontaneously without clear aetiology. The aim of this study was to evaluate whether a longer follow-up period, on a larger group, supports the previous findings.

View Article and Find Full Text PDF